Identification of New Nitric Oxide-Donating Peptides with Dual Biofilm Eradication and Antibacterial Activities for Intervention of Device-Related Infections

Yue Fei,Jianbing Wu,Hong-Wei An,Kai Zhu,Bo Peng,Junquan Cai,Yihua Zhang,Li-Li Li,Hao Wang,Zhangjian Huang
DOI: https://doi.org/10.1021/acs.jmedchem.9b01832
IF: 8.039
2020-08-05
Journal of Medicinal Chemistry
Abstract:Implantable medical device-related infections with biofilms have become a significant challenge in clinics. Based on the potential bacteria biofilm dispersing effect of nitric oxide (NO) and the unique antibacterial activity of antimicrobial peptides (AMP), we synthesized five peptides and selected the most potent one to conjugate its N-terminal with a furoxan moiety to offer a hitherto unknown NO-donating antimicrobial peptide (<b>FOTyr-AMP</b>), which exhibited <i>Staphylococcus aureus</i> and <i>Escherichia coli</i> biofilm dispersion and eradication, and potent antibacterial activities in vitro. In an implanted biofilm infection mice model, topical subcutaneous injection of <b>FOTyr-AMP</b> allowed synergetic eradication of bacterial biofilms and potent antibacterial activity, superior to the antibiotic cephalosporin C. Given the low hemolysis effect, little influence on the blood pressure, and potent in vivo efficacy of <b>FOTyr-AMP</b>, it is clear that subcutaneous administration of <b>FOTyr-AMP</b> could be a promising approach for the intervention of medical device-related biofilm infections with desirable safety.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01832?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01832</a>.Mechanism of GSH-mediated NO release from furoxan and synthetic schemes for peptides <b>1</b>–<b>5</b> and FOTyr-AMP; Scheme S1: mechanism of GSH-mediated NO release from furoxan; Scheme S2–S6: synthetic routes of peptides <b>1</b>–<b>5</b>; Scheme S7: synthetic route of <b>FOTyr-AMP</b>; Table S1: MIC values of different peptides against <i>S. aureus</i> and <i>E. coli</i>; Table S2: NO release from FOTyr and <b>FOTyr-AMP</b>; Table S3: NO release from <b>FOTyr-AMP</b> in <i>S. aureus</i> with or without the pretreatment of CDNB; Table S4: MIC values of FOTyr, AMP, and <b>FOTyr-AMP</b> against <i>S. aureus</i> and <i>E. coli</i>; and Table S5: effect of <b>FOTyr-AMP</b> and saline on blood pressure; Figures S1: hemolysis effect of AMP and <b>FOTyr-AMP</b>; Figure S2: quantitative calculation of biofilm biomass; Figures S3 and S4: biofilm index from 0 to 24 h; and Figure S5: biofilm index of <i>S. aureus</i> by the treatment of the test compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01832/suppl_file/jm9b01832_si_001.pdf">PDF</a>)Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01832/suppl_file/jm9b01832_si_002.csv">CSV</a>)This article has not yet been cited by other publications.
chemistry, medicinal
What problem does this paper attempt to address?